Demographic and clinical data for a cohort of liver transplant recipients who developed AKI after transplant surgery.
| Sex | |
| Male | 56% |
| Female | 44% |
| Age (years) | 53.5 ± 11.3 |
| Race | |
| Caucasian | 85% |
| African | 3% |
| Hispanic | 9% |
| Asian | 3% |
| Body mass index (kg/m2) | 27.5 ± 5.03 |
| Presurgery plasma 8OHdG (ng/ml) | 11.8 ± 8.14 |
| Postsurgery plasma 8OHdG (ng/ml) | 16.3 ± 11.8 |
| Presurgery plasma THP (ng/ml) | 291 ± 258 |
| Postsurgery plasma THP (ng/ml) | 102 ± 93.6 |
| Presurgery eGFR (ml/min per 1.73 m2) | 67.8 ± 33.0 |
| Presurgery plasma creatinine (mg/dl) | 1.32 ± 0.807 |
| Postsurgery plasma creatinine (mg/dl) | 1.53 ± 0.689 |
| AKI stage | |
| Stage 1 | 15% |
| Stage 2 | 29% |
| Stage 3 | 56% |
| Received dialysis | 47% |
| Sixty-day survival | 77% |